CATX – perspective therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $16.00. They now have an "outperform" rating on the stock.
Perspective Therapeutics, Inc. (NYSE: CATX) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $24.00.
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $22.00 to $16.00. They now have an "outperform" rating on the stock.
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock, down previously from $20.00.
Form 4 Perspective Therapeutics For: Dec 04 Filed by: HENSON HEIDI
Form 4 Perspective Therapeutics For: Dec 04 Filed by: Spoor Johan M.
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Williamson Robert F III
Form 4/A Perspective Therapeutics For: Nov 25 Filed by: Spoor Johan M.
Form 8-K Perspective Therapeutics For: Dec 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.